These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 17661457

  • 21. Quantitative structure-activity relationship studies of HIV-1 integrase inhibition. 1. GETAWAY descriptors.
    Saíz-Urra L, González MP, Fall Y, Gómez G.
    Eur J Med Chem; 2007 Jan; 42(1):64-70. PubMed ID: 17030481
    [Abstract] [Full Text] [Related]

  • 22. 4D-fingerprints, universal QSAR and QSPR descriptors.
    Senese CL, Duca J, Pan D, Hopfinger AJ, Tseng YJ.
    J Chem Inf Comput Sci; 2004 Jan; 44(5):1526-39. PubMed ID: 15446810
    [Abstract] [Full Text] [Related]

  • 23. Quantitative structure-based design: formalism and application of receptor-dependent RD-4D-QSAR analysis to a set of glucose analogue inhibitors of glycogen phosphorylase.
    Pan D, Tseng Y, Hopfinger AJ.
    J Chem Inf Comput Sci; 2003 Jan; 43(5):1591-607. PubMed ID: 14502494
    [Abstract] [Full Text] [Related]

  • 24. Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.
    Deng J, Lee KW, Sanchez T, Cui M, Neamati N, Briggs JM.
    J Med Chem; 2005 Mar 10; 48(5):1496-505. PubMed ID: 15743192
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
    Gupta P, Garg P, Roy N.
    Chem Biol Drug Des; 2012 May 10; 79(5):835-49. PubMed ID: 22233531
    [Abstract] [Full Text] [Related]

  • 33. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T, Fuji M, Yoshinaga T, Sato A, Fujiwara T, Kiyama R.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8420-9. PubMed ID: 17005407
    [Abstract] [Full Text] [Related]

  • 34. Cluster analysis and two-dimensional quantitative structure-activity relationship (2D-QSAR) of Pseudomonas aeruginosa deacetylase LpxC inhibitors.
    Kadam RU, Roy N.
    Bioorg Med Chem Lett; 2006 Oct 01; 16(19):5136-43. PubMed ID: 16879960
    [Abstract] [Full Text] [Related]

  • 35. Constructing optimum blood brain barrier QSAR models using a combination of 4D-molecular similarity measures and cluster analysis.
    Pan D, Iyer M, Liu J, Li Y, Hopfinger AJ.
    J Chem Inf Comput Sci; 2004 Oct 01; 44(6):2083-98. PubMed ID: 15554679
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.